Claudia Nabaie

Claudia Nabaie is an experienced communications professional with a focus on international markets and corporate communications. Currently serving as Director of International Communications at Blueprint Medicines since March 2025, Claudia has held similar leadership roles at Apellis Pharmaceuticals and Global Blood Therapeutics. Claudia has also contributed to multiple organizations, including bluebird bio, Biogen, and Roche, bringing expertise in corporate affairs and public relations. Claudia's academic background includes a Master of Arts in Business Communication and Economics from Technische Universität Dresden and further studies at Temple University Japan.